Mumbai, October 27, 2025. Sanofi India Limited (SIL) today announced that its Board of Directors, on the recommendation of the Nomination and Remuneration Committee, has appointed Deepak Arora as the Company’s Managing Director with effect from October 27, 2025, subject to the approval of the shareholders and the Central Government.
In this role, Deepak will define and drive the strategic vision for India in alignment with Sanofi’s global strategy. He will also spearhead strategic priorities to accelerate innovation and agility throughout the organization, while fostering operational excellence across all functions.
Furthermore, Deepak will champion the Company’s Diversity, Equity, and Inclusion culture to bring our core values to life.
Deepak brings over 30 years of experience in the Pharmaceutical & Healthcare industry across North America, Europe, Middle East and Africa. He has held leadership positions in Commercial, Sales & Marketing, and General Management roles, acquiring businesses and generating sustainable growth within several multinational companies.
Aditya Narayan, Chairman of the Board, Sanofi India Limited
“On behalf of the Board of Directors, I am delighted to welcome Deepak Arora as the Managing Director. His extensive pharmaceutical experience across diverse geographies aligns perfectly with our endeavour to serve patients throughout India. We are confident that under his leadership, Sanofi will continue to thrive and innovate. We extend our wholehearted support and best wishes as he embarks on this significant journey.”
Deepak holds a Bachelor’s degree in Botany & Zoology from the University of Lucknow and is an MBA from the Indira Gandhi National Open University.
Sanofi in India
Present in India for nearly seven decades, Sanofi has earned the trust of customers and stakeholders for its commitment to promoting health. As Sanofi chases the miracles of science to improve people’s lives, it continues to engage across the entire health spectrum from prevention with vaccines to wellness, treatment, patient support & capacity building.
Sanofi’s India Charitable Access Program (InCAP) is the country’s longest running humanitarian program providing free treatment to people afflicted with Lysosomal Storage Disorders. Sanofi conducts clinical trials in India, so that the country can have quicker access to the latest from the company’s global pipeline. Sanofi India’s world-class manufacturing site in Goa produces for people in India and 60+ other countries. Sanofi has located one of its global talent hubs in Hyderabad, India, from where wide range of services are provided globally.
Recognized by the ‘Top® Employers Institute’ – a global authority that honours excellence in people practices since 2019, Sanofi’s local entities include Sanofi India Limited (SIL – listed entity), and Sanofi Healthcare India Pvt. Ltd. (SHIPL).
